# Effectiveness of Gabapentin on Chronic Irritability in Neurologically Impaired Children

> **NCT01675960** · PHASE2 · TERMINATED · sponsor: **Gillette Children's Specialty Healthcare** · enrollment: 2 (actual)

## Conditions studied

- Neurologically Impaired
- Irritable Mood
- Signs and Symptoms, Digestive
- Sleeplessness
- Chronic Pain

## Interventions

- **DRUG:** Gabapentin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01675960
- **Lead sponsor:** Gillette Children's Specialty Healthcare
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-04
- **Primary completion:** 2017-07
- **Final completion:** 2017-07
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** unable to enroll
- **Last updated:** 2019-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01675960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01675960, "Effectiveness of Gabapentin on Chronic Irritability in Neurologically Impaired Children". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01675960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*